Loperamide toxicity: recommendations for patient monitoring and management.

导出原文传递

翻译打印收藏纠错

作者： William,Eggleston ^[1] ; Robert,Palmer ^[2] ; Pierre-André,Dubé ^[3] ; Stephen,Thornton ^[4] ; Andrew,Stolbach ^[5] ; Diane P,Calello ^[6] ; Jeanna M,Marraffa ^[7]

作者单位： School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, USA. ^[1] Department of Emergency Medicine, Upstate Medical University, Upstate New York Poison Center, Syracuse, NY, USA. ^[2] Toxicology Associates, Littleton, CO, USA. ^[3] Department of Environmental Health and Toxicology, Institut National de Santé Publique du Québec, Quebec, Canada. ^[4] Emergency Medicine, University of Kansas Medical Center, Kansas City, KS, USA. ^[5] Poison Control Center, University of Kansas Health System, Kansas City, KS, USA. ^[6] Emergency Medicine, Johns Hopkins University, Baltimore, MD, USA. ^[7] Rutgers New Jersey Medical School, Department of Emergency Medicine, New Jersey Poison Information and Education System, Newark, NJ, USA. ^[8]

关键词 Loperamide cardiac toxicity substance use disorder

主题词人类(Humans);洛哌丁胺(Loperamide);监测, 生理学(Monitoring, Physiologic);物质相关性障碍(Substance-Related Disorders)

DOI 10.1080/15563650.2019.1681443

PMID 31684751

发布时间 2020-10-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交